Log in

Relevant bibliographies by topics / Ophthalmic pharmaceuticals

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers

Academic literature on the topic 'Ophthalmic pharmaceuticals'

Author: Grafiati

Published: 3 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Ophthalmic pharmaceuticals.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Ophthalmic pharmaceuticals"

1

Md., Sahab Uddin, Al Mamun Abdullah, Tanvir Kabir Md., et al. "Quality Control Tests for Ophthalmic Pharmaceuticals: Pharmacopoeial Standards and Specifications." Journal of Advances in Medical and Pharmaceutical Sciences 14, no. 2 (2017): 1–17. https://doi.org/10.9734/JAMPS/2017/33924.

Full text

Abstract:

The therapeutically performance of the pharmaceuticals must be constant and expectable. In order to claim a pharmaceutical to be a quality drug, it must fulfill certain standards and specifications. The quality of pharmaceuticals is strongly related to the patient’s well-being. Quality control (QC) is an historical process in which proof is obtained that the appropriate level of quality has been achieved. QC can have no effect on the quality of the pharmaceuticals. It is merely a measuring process. QC must ensure that all the finished products contain active ingredients that comply with the qu

APA, Harvard, Vancouver, ISO, and other styles

2

Clarkson, Douglas. "Nanotechnology in ophthalmology: An update." Optician 2017, no. 7 (2017): 6603–1. http://dx.doi.org/10.12968/opti.2017.7.6603.

Full text

Abstract:

Developments in nanotechnology present new opportunities in treatment of ocular disease and in the evolution of ophthalmic pharmaceuticals. Dr Douglas Clarkson offers an update on this new area of healthcare.

APA, Harvard, Vancouver, ISO, and other styles

3

Meagher, Andrew, and G. Richard Bennett. "Klinische Anwendung von Rhopressa: Eine Fallserie." Optometry & Contact Lenses 3, no. 1 (2022): 20–29. http://dx.doi.org/10.54352/dozv.xqja4215.

Full text

Abstract:

Purpose. The aim of this paper is to discuss and highlight via case reports the effective use of Rhopressa in three individual cases of Primary Open-Angle Glaucoma (POAG) treated at a glaucoma clinic in Philadelphia, PA, USA. The cases display the clinical use of netarsudil and reviews therapeutic approach- es to combating the side effects of conjunctival hyperemia associated with netarsudil. Material and Methods. A systematized PubMed literature search based on the terms “Rhopressa”, “netarsudil”, “ROCK inhibition” was conducted. Six eyes of three adult patients were monitored for three month

APA, Harvard, Vancouver, ISO, and other styles

4

Uddin, Md, Abdullah Mamun, Md Kabir, et al. "Quality Control Tests for Ophthalmic Pharmaceuticals: Pharmacopoeial Standards and Specifications." Journal of Advances in Medical and Pharmaceutical Sciences 14, no. 2 (2017): 1–17. http://dx.doi.org/10.9734/jamps/2017/33924.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Papava, Medea V., and Nana J. Gaprindashvili. "The Efficacy and Safety of Topical Cyclosporine A and its Generic Equivalency Depores Eye Drops in The Treatment of Dry Eye Disease." Caucasus Journal of Medical and Psychological Sciences 2, no. 1-2 (2024): 50–68. http://dx.doi.org/10.61699/cjmps-v2-i1-2-p50-68.

Full text

Abstract:

Dry eye disease (DED) is a complex condition that can result in significant vision complications. Analyzing systematic reviews of DED treatment contributes to selecting the most effective and safe drug. This review examines the efficacy of cyclosporine A and the generic Depores ophthalmic emulsion cyclosporine 0.05% (cyclosporine 0.05%, Deva Pharmaceuticals, Turkey) in the treatment of DED. A search for scientific information in PubMed, PubMed Central, The Cochrane Library, Google Scholar databases, and the Internet was carried out using keywords: dry eye disease, Cyclosporine A, Ikervis, Rest

APA, Harvard, Vancouver, ISO, and other styles

6

Inam, Onur, Ersin Demir, and Bengi Uslu. "Voltammetric Pathways for the Analysis of Ophthalmic Drugs." Current Pharmaceutical Analysis 16, no. 4 (2020): 367–91. http://dx.doi.org/10.2174/1573412915666190225163637.

Full text

Abstract:

Background: This review investigates the ophthalmic drugs that have been studied with voltammetry in the web of science database in the last 10 years. Introduction: Ophthalmic drugs are used in the diagnosis, evaluation and treatment of various ophthalmological diseases and conditions. A significant literature has emerged in recent years that investigates determination of these active compounds via electroanalytical methods, particularly voltammetry. Low cost, rapid determination, high availability, efficient sensitivity and simple application make voltammetry one of the most used methods for

APA, Harvard, Vancouver, ISO, and other styles

7

VYAS, URVASHI, NARENDRA GEHALOT, VIKAS JAIN, and S. C. MAHAJAN. "A REVIEW ON IN SITU GELLING SYSTEM FOR OPHTHALMIC DRUG DELIVERY." Current Research in Pharmaceutical Sciences 11, no. 4 (2022): 98–106. http://dx.doi.org/10.24092/crps.2021.110402.

Full text

Abstract:

Ophthalmic drug delivery systems are both fascinating and problematic due to the normal physiological properties of the eyes, which restrict ocular product bioavailability. The development of novel ocular dosage forms for current drugs in order to enhance efficacy and bioavailability, as well as patient compliance and convenience, has become a major focus in the pharmaceutical business. Ocular In-situ gelling systems are a novel type of eye drug delivery systems that begin as a solution but rapidly convert into a thick gel when implanted or inserted into an ocular cavity where active pharmaceu

APA, Harvard, Vancouver, ISO, and other styles

8

Abdelkader, H., B. Pierscionek, M. Carew, Z. Wu, and R. G. Alany. "Critical appraisal of alternative irritation models: three decades of testing ophthalmic pharmaceuticals." British Medical Bulletin 113, no. 1 (2015): 59–71. http://dx.doi.org/10.1093/bmb/ldv002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Cable, Melissa Morrison. "Review of Bromfenac Ophthalmic Solution 0.09 % Once-daily." US Ophthalmic Review 05, no. 01 (2012): 37. http://dx.doi.org/10.17925/usor.2012.05.01.37.

Full text

Abstract:

Bromfenac ophthalmic solution 0.09 % (BROMDAY™, ISTA Pharmaceuticals, Inc., Irvine, CA) is the first and only once-daily topical ophthalmic non-steroidal anti-inflammatory drug (NSAID) approved by the Food and Drug Administration for the treatment of post-operative pain and inflammation following cataract surgery. Topical NSAIDs are important following surgery to enhance patient comfort and limit inflammation, which may otherwise restrict visual rehabilitation. In a recently published study looking at Early Treatment Diabetic Retinopathy Study (ETDRS) acuities and macular optical computed tomo

APA, Harvard, Vancouver, ISO, and other styles

10

Ergen, Harun, Muge Guleli, Cigdem Sener, Cem Caliskan, Sercan Semiz, and Mahmut Ozbek. "Development and Validation of a Novel Reversed Phase High Performance Liquid Chromatography with Refractive Index Detector Method for Assay of Polyvinyl Alcohol in an Ophthalmic Solution." Current Pharmaceutical Analysis 16, no. 7 (2020): 867–71. http://dx.doi.org/10.2174/1573412915666190304152901.

Full text

Abstract:

Introduction: Polyvinyl alcohol (PVA), a polymer, is in demand due to its usage in different applications such as pharmaceutical, biomedical and textile, paper, food industries. Methods: A new sensitive reversed phased high-pressure liquid chromatography (RP-HPLC) method with refractive index detector (RID) was developed for determination of PVA in an ophthalmic solution containing dexpanthenol and PVA as active substances and it was validated according to The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guideline. Results: Chromatog

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Ophthalmic pharmaceuticals"

1

Zachar, Carrie L. "Pharmaceutically Relevant Microemulsions with Potential Topical, Ophthalmic, and Parenteral Applications." University of Toledo / OhioLINK, 2010. http://rave.ohiolink.edu/etdc/view?acc_num=toledo1271273404.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Fitzgerald, P. "An assessment of the precorneal residence of ophthalmic drug delivery systems." Thesis, University of Nottingham, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.356556.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Meslard, Jean-Claude. "Immobilisation temporaire de medicaments par des liaisons hydrolysables sur des polymeres biocompatibles : application a l'ophtalmologie." Paris 6, 1988. http://www.theses.fr/1988PA066417.

Full text

Abstract:

L'objectif est l'immobilisation reversible de medicaments (chloramphenicol, indometacine) au sein de lentilles de contact hydrophiles permettant une liberation lente et continue lors de leur adaptation sur des yeux malades

APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Ophthalmic pharmaceuticals"

1

Dornic, Dean. Ophthalmic pocket companion. 5th ed. Butterworth-Heinemann, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Frost & Sullivan., ed. World ophthalmic pharmaceutical markets: Technology-driven products for shifting global economies. Frost & Sullivan, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Rhee, Douglas J. The Wills eye drug guide: Diagnostic and therapeutic medications. Lippincott-Raven, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Optometry, Virginia Board of, Virginia Board of Pharmacy, and Virginia. Dept. of Health Professions., eds. Regulations of the Virginia Board of Optometry, title of regulations 18 VAC 105-20-10 et seq., effective date January 15, 2003: Statutes relating to the practice of optometry, 2002 ; regulations for certification for therapeutic pharmaceutical agents, title of regulations 18 VAC 105-20-10 et seq., effective date January 15, 2003 ; drug laws for TPA certified optometrists. Dept. of Health Professions, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Bartlett, Jimmy D. Od. Ophthalmic Drug Facts 2001 (Ophthalmic Drug Facts). Facts and Comparisons, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Mitra, Ashim K. Ophthalmic Drug Delivery Systems, Second Edition (Drugs and the Pharmaceutical Sciences). 2nd ed. Informa Healthcare, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Bartlett, Jimmy D. Ophthalmic Drug Facts, 2000. Facts and Comparisons, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

(Philadelphia, Pa ). Wills Eye Hospital. The Wills Eye Drug Guide: Diagnostic and Therapeutic Medications. 2nd ed. Lippincott Williams & Wilkins, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Ophthalmic pharmaceuticals"

1

Wilson, Clive G. "Chapter 1. Ophthalmic Formulation." In Specialised Pharmaceutical Formulation. Royal Society of Chemistry, 2022. http://dx.doi.org/10.1039/9781839165603-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Bhawale, Rohit, Vaibhavi Srivastava, and Neelesh Kumar Mehra. "Advances in Ophthalmic Formulation Development." In Advances in Pharmaceutical Product Development. Springer Nature Singapore, 2025. https://doi.org/10.1007/978-981-97-9230-6_12.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Brunaugh, Ashlee D., Hugh D. C. Smyth, and Robert O. Williams III. "Ophthalmic and Otic Drug Delivery." In AAPS Introductions in the Pharmaceutical Sciences. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-31745-4_8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Brunaugh, Ashlee D., Daniel Moraga-Espinoza, Tania Bahamondez-Canas, Hugh D. C. Smyth, and Robert O. Williams. "Ophthalmic and Otic Drug Delivery." In AAPS Introductions in the Pharmaceutical Sciences. Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-52520-9_9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Sharma, Sandeep, Varsha Narayanan, Manoj Mahajan, and Y. S. V. S. Naga Mohan. "Ophthalmic Pharmaceutical Markets South-East Asia Region Perspective 2020." In South-East Asia Eye Health. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-3787-2_35.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Suri, Reshal. "Design of Experiments for the Development of Ophthalmic Products." In Design of Experiments for Pharmaceutical Product Development. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-33-4351-1_7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Müller-Goymann, Christel C., and Mukta Paranjpe. "Nanodrugs in Medicine and Healthcare: Pulmonary, Nasal and Ophthalmic Routes, and Vaccination." In Pharmaceutical Nanotechnology: Innovation and Production. Wiley-VCH Verlag GmbH & Co. KGaA, 2016. http://dx.doi.org/10.1002/9783527800681.ch26.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Deepika, B., Rajini Kolure, B. Uma Rajeshwari, P. Naga Haritha, and B. Suhasini. "Evaluation of the Relationship between Ocular Damage and Monocular Blindness Related to Ophthalmic Illness." In Recent Developments in Microbiology, Biotechnology and Pharmaceutical Sciences. CRC Press, 2025. https://doi.org/10.1201/9781003618140-163.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Herrero-Vanrell, Rocío. "Ophthalmic Pharmaceuticals: New Formulations." In Ocular Pharmacotherapy. Jaypee Brothers Medical Publishers (P) Ltd., 2017. http://dx.doi.org/10.5005/jp/books/12924_2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

DOUGHTY, M. "Ophthalmic pharmaceuticals, their formulation and use." In Ocular Pharmacology & Therapeutics. Elsevier, 2001. http://dx.doi.org/10.1016/b978-0-7506-4520-1.50008-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Ophthalmic pharmaceuticals"

1

Sandhu, Jaspal S., Aman Bhandari, Mahad Ibrahim, and P. Balakrishnan. "Appropriate Design of Medical Technologies for Emerging Regions: The Case of Aurolab." In ASME 2005 International Mechanical Engineering Congress and Exposition. ASMEDC, 2005. http://dx.doi.org/10.1115/imece2005-81291.

Full text

Abstract:

Healthcare delivery in emerging regions presents a unique set of challenges and is characterized largely by poor infrastructure. Though there is significant variation from country to country - and even within countries - in emerging regions, common themes emerge, such as overreliance on direct payment schemes, unreliable supply chains, and intermittent power in rural settings. These themes in turn impose particular design requirements on manufacturers of medical devices and pharmaceuticals; this paper focuses on these design requirements. We illustrate the importance of designing specifically

APA, Harvard, Vancouver, ISO, and other styles

2

L. Kiss, Eszter, Erzsébet Csányi, and Mária Budai-Szűcs. "Nanostructured lipid carriers for ophthalmic use." In II. Symposium of Young Researchers on Pharmaceutical Technology,Biotechnology and Regulatory Science. Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, 2020. http://dx.doi.org/10.14232/syrptbrs.2020.op16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Szalai, Boglárka, Orsolya Jójárt-Laczkovich, and Mária Budai-Szűcs. "Evaluation of combined thermoresponsive ophthalmic gels." In VI. Symposium of Young Researchers on Pharmaceutical Technology,Biotechnology and Regulatory Science. Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, 2024. http://dx.doi.org/10.14232/syrptbrs.2024.22.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

L. Kiss, Eszter, Mária Budai-Szűcs, and Erzsébet Csányi. "Mucoadhesive nanostructured lipid carriers for ophthalmic use." In III. Symposium of Young Researchers on Pharmaceutical Technology,Biotechnology and Regulatory Science. Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, 2021. http://dx.doi.org/10.14232/syrptbrs.2021.op15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Bíró, Tivadar, and Zoltán Aigner. "Novel ophthalmic formulations to increase the efficacy and stability." In I. Symposium of Young Researchers on Pharmaceutical Technology,Biotechnology and Regulatory Science. Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, 2019. http://dx.doi.org/10.14232/syrptbrs.2019.op15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

L. Kiss, Eszter, Mária Budai-Szűcs, and Erzsébet Csányi. "Improving the ophthalmic bioavailability of steroidal anti-inflammatory drugs." In I. Symposium of Young Researchers on Pharmaceutical Technology,Biotechnology and Regulatory Science. Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, 2019. http://dx.doi.org/10.14232/syrptbrs.2019.op7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Victoria, Díaz, García Xurxo, Varela Rubén, Blanco Guillermo, Fernández Anxo, and Otero Francisco J. "<em>In vitro</em> and <em>in vivo</em> ophthalmic bioadhesion and ocular safety characterization of cyclodextrin based solution." In The 1st International Electronic Conference on Pharmaceutics. MDPI, 2020. http://dx.doi.org/10.3390/iecp2020-08789.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!